https://sciex.com/content/SCIEX/na/us/en


Should you bring your PFAS testing in-house?

Feb 18, 2021 | Blogs, Environmental / Industrial | 0 comments

Read time: 4 minutes

As the per- and polyfluoroalkyl substances (PFAS) regulatory landscape evolves in the US and across the globe, the interest in PFAS continues to grow. Drinking water and food packaging are under particular scrutiny, and monitoring programs and requirements will continue to expand to include an increasing variety of sample types and PFAS compounds.

Organizations that adhere to these regulatory demands will be under increasing pressure to control costs as sample volumes increase. Acquiring high-quality instrumentation and PFAS analysis training is a potentially valuable cost-containment approach for any labs that require ongoing PFAS testing.  

Here, I have outlined some key considerations that may help you decide to bring PFAS testing in-house.  

1. Cost

The cost of third-party analysis can quickly add up to several hundred dollars per sample, especially in resampling cases due to contamination. As your testing needs grow, increasing testing volume and complexity will raise your testing program’s costs. Acquiring your instrumentation along with highly specialized PFAS-focused training from SCIEX will allow you to control the costs of testing as your test volume and complexity increase.

2. Turnaround time (TAT):

Timely PFAS testing results are needed to make quick decisions regarding the treatment and mitigation of PFAS contamination to meet regulatory requirements and protect public health. Rapid turnaround times within 24 hours, if they are commercially available at all, are cost-prohibitive in most situations. With in-house instrumentation, turnaround times of less than 24 hours can be achieved at a lower cost using fewer resources.

3. Quality assurance and quality control (QA/QC):

Testing PFAS samples in-house provides greater visibility into the entire process for your whole QA/QC system and for troubleshooting difficult samples. SCIEX can help you develop robust and highly accurate methods and automate your PFAS analysis protocol from sample preparation through data reporting to further increase the precision of the results and consistently meet QA/QC requirements.

4. Method flexibility:

PFAS contamination investigations sometimes require creative and flexible sampling and analysis protocols to track sources of contamination. This could involve performing swabs of potentially contaminated sampling environments for source tracking, performing serial dilutions of heavily contaminated samples, using direct-injection dilute-and-shoot methods for rapid screening of large numbers of samples, confirming positive identifications with full-scan methods or screening for novel PFAS that are not available at commercial testing labs.

These are just a few benefits of bringing your PFAS testing in-house. If you’re interested, check out this 1-page white paper on how the unique combination of industry-leading expertise, analytical equipment systems and consumables of SCIEX and Phenomenex can help you achieve high-quality PFAS analysis.

Do you have questions about how we can help? Feel free to either comment below or email me directly at simon.roberts@sciex.com. Thanks for reading.

Why not check out my Youtube channel Environmental Chemistry Explained

RUO-MKT-18-1266 -A


A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Supporting new CRISPR gene editing systems

Prime editing (PE) is a next-generation gene editing technology that utilizes a Cas9 protein fused to a prime editing guide ribonucleic acid (pegRNA) to achieve high CRISPR/Cas9 editing efficiency and precision. However, the length requirement of pegRNAs at 120–250 nucleotides (nt) and their high level of secondary structure formation present analytical challenges for the purity analysis of chemically synthesized pegRNAs during development and quality control (QC).

Posted by

Simon Roberts specializes in developing methods for PFAS analysis at SCIEX for both targeted and non-targeted analysis. Before working at SCIEX, Simon performed PFAS discovery research at Colorado School of Mines during his postdoctoral fellowship. He worked on projects that identified dozens of novel PFAS in groundwater and industrial chemicals. Recently, Simon has focused on educating the public about PFAS via his YouTube channel Environmental Chemistry Explained.

Tags


0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial